8The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995,333(5) : 1580-1587.
9Tomsick T, Brott T, Barsan W, et al. Prognostic Value of the hyperdensc middle cerebral artery sign and stroke scale score before ultra early thrombdytic therapy. AJNR Am J Neuroradiol, 1996,17(1):79-85.
2Patel SC, Mody A. Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovasc Dis, 1999,42(3) :217-233.
3Wardlaw JM, Sandercock PA, Warlow CP, et al. Trials of thrombolysis in acute ischemic stroke: does the choice of primary outcome measure really matter? Stroke, 2000, 31(5): 1133-1135.
5Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke, 1994, 25(2): 298-303.
6Sakurama T, Kitamura R, Kaneko M. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke. Stroke, 1994, 25(2): 451-456.
7Jaillard A, Comu C, Durieux A, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke,1999, 30(7): 1326-1332.
8Kano T, Katayama Y, Tejima E, et al. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res, 2000, 854(1-2): 245-248.
9Lodder J, Krijne Kubat B, Broekman J. Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke, 1986, 17(4): 626-629.
10Bozzao L, Angeloni U, Bastianello S, et al. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol, 1991, 12 (6):1115-1121.
